-
Gene Editing Startup CRISPR Therapeutics Plots IPO
Boston Business Journal | The question remains whether CRISPR can do much better on the stock market than the other two publicly-traded gene editing companies, both of which are based in Cambridge and held IPOs earlier this year.
Sep 12, 2016
-
George Church May Be Called To Testify In CRISPR Fight
STAT | The University of California believes the visionary bioengineer will undermine key assertions made by the Broad Institute of Harvard and MIT.
Sep 8, 2016
-
Genentech To Get Multi-Million Tax Refund
San Mateo Daily Journal | Biotech company Genetech will receive a multi-million dollar refund on its tax bill, alleging it was assessed too much for machines and equipment; San Mateo County appeals decision.
Sep 8, 2016
-
Moderna Closes $474M Equity Financing
Bio-IT World Brief | Moderna Therapeutics announced today that it has raised $474 million. The company currently has $1.4 billion in cash on its balance sheet and the potential for over $230 million of additional available funds from grants.
Sep 7, 2016
-
First DNA Sequencing In Space A Success
Bio-IT World News | NASA has released a statement saying that the first DNA sequencing in space has occurred on the International Space Station.
Sep 7, 2016
-
Mylan Rebuffs Rumors CEO Will Step Down
BioSpace Mylan denies rumors that CEO will step down after controversy regarding EpiPen Auto-Injector.
Sep 6, 2016
-
tranSMART Foundation Launches Online Marketplace
Bio-IT World The tranSMART Foundation has launched a free marketplace of service vendors for the tranSMART platform. The marketplace was developed by tranSMART as a way to localize the vast world of data research and the vendors who offer services within that field.
Sep 2, 2016


